Efficacy and Safety of AZD4547 Versus Paclitaxel in Patients With Advanced Gastric or Gastro-oesophageal Cancer

NCT01457846 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

960

Enrollment

INDUSTRY

Sponsor class

Conditions

Gastro-oesophageal Junction Cancer
Gastric Cancer

Interventions

DRUG: AZD4547
DRUG: paclitaxel

Sponsor

AstraZeneca